Dx Start-Ups: Separating the Wheat From the Chaff
This article was originally published in Start Up
Executive Summary
The diagnostics industry has been a tarpit for start-ups. Entrepreneurs rarely overcome the field's serious and often unseen challenges, but a handful are thriving thanks to their realistic assessments of just how complex the industry is and their ability to adapt when products hit brick walls. Accessible market niches are a key to success, so is exploiting drug firms--as customers, marketing channels, or as sources of differentiating technology.
You may also be interested in...
Warburg Pincus Teams with Cytyc Duo
Warburg Pincus joined with two executives who built Cytyc into a leading women's health care company. Together, they hope to identify a new venture for the pair to lead with the private equity firm's support.
Exact Sciences' Moment
Exact Sciences and its distribution partner, LabCorp are on the verge of launching a new molecular test for colon cancer screening. They've taken deal-making in diagnostics to a new level, but now they have to deliver on their promises.
Exact Sciences' Moment
Exact Sciences and its distribution partner, LabCorp are on the verge of launching a new molecular test for colon cancer screening. They've taken deal-making in diagnostics to a new level, but now they have to deliver on their promises.